Accendra Health, Inc. (ACH)
NYSE · Healthcare
Accendra Health, Inc. EBITDA 2008–2025
Accendra Health, Inc. annual/quarterly ebitda history and growth rate from 2008 to 2026. EBITDA stands for Earnings Before Interest, Taxes, Depreciation and Amortization. It is widely used as a measure of core operational profitability.
- Accendra Health, Inc. ebitda for the quarter ending March 31, 2026 was 78.9 M, a 25.80% increase year-over-year.
- Accendra Health, Inc. ebitda for the twelve months ending March 31, 2026 was 315.1 M, a 8.66% decrease year-over-year.
- Accendra Health, Inc. annual ebitda for 2025 was 242.0 M, a 763.90% decrease from 2024.
- Accendra Health, Inc. annual ebitda for 2024 was -36.4 M, a 110.61% decrease from 2023.
- Accendra Health, Inc. annual ebitda for 2023 was 343.6 M, a 7.53% decrease from 2022.
- Accendra Health, Inc. annual ebitda for 2022 was 371.6 M.
EBITDA
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Accendra Health, Inc. EBITDA — FAQ
Accendra Health, Inc. (ACH) ebitda over the last 18 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ACH's ebitda history?
The chart and table above show Accendra Health, Inc.'s ebitda by year and by quarter, including the growth rate.